Code Bio
Sai Abhishek has a diverse background in healthcare venture capital, investment banking, and biotechnology research. Currently leading strategy and business development at Code Biotherapeutics, focusing on genetic medicines. Previously, worked at New Enterprise Associates and Credit Suisse in healthcare investment banking and venture capital. Holds a Bachelor of Science degree from The Wharton School with concentrations in Finance, Statistics, and a Biology minor. Past research experiences include DNA nanotechnology and chemotherapy research at Cornell University and Penn Engineering.
This person is not in the org chart
This person is not in any offices
Code Bio
Code Biotherapeutics is an emerging next-generation gene therapy company pioneering the development of targeted non-viral gene therapies to treat serious and life-threatening genetic diseases not well served by other gene therapy technologies.